By Gary G. Kohls, MD
Despite the fact that I am a physician, I have long been suspicious of the influence of giant multinational medical corporate cartels that are best referred to as Big Pharma, Big Vaccine, Big Medicine, Big Insurance, Big Food, Big Agrichemical, etc. Most clear-headed observers of these industries (that meet the psychiatrist’s DSM definition of sociopathic entities) are justifiably concerned about the inordinate influence that they have over the mainstream media and most of our political parties, legislators and presidents.
These mega-corporations and their cunning multibillionaire owners (the 0.01%) are the paymasters of every politician and political party that thinks that they has to have millions of dollars in their campaign coffers in order to keep their political offices safe. Those paymasters, as is the case with all their other “investments”, expect a handsome long-term return on those investments. Those entities with excess luxury wealth are very serious when it comes to their money. That is why they can be so ruthless when it comes to getting what they want from their stable of politicians, lawyers and the publishers and editors of their newspapers and their television and radio stations.
My consciousness concerning the innate corruption in the vaccine industry was sharply raised when my father (in the totally bogus 1976 Swine Flu that NEVER materialized!) had the peripheral nerves to his hands poisoned by the neurotoxic mercury-containing Swine Flu vaccine. The small muscles that had been previously innervated by both of his radial nerves became permanently paralyzed. Within days the poisonous heavy metal in that vaccine caused a classical Guillain-Barre syndrome that he never recovered from. He never did regain his mastery of what was his lifelong love - fishing
In a now frequently repeated scenario (the latest ones being the Ebola virus “pandemic” and now the equally bogus Zika virus/microcephaly epidemic), the vaccine industry’s lobbyists are successfully capitalizing on what is very likely an iatrogenic illness (physician or medicine-caused disease). And the public health agencies (all indoctrinated into believing the med school myths that all vaccines are safe and effective) are scaring the wits out of us with plausible, but unproven theories about another vaccine-preventable epidemic.
Then, with the constant stream of propaganda from the once respected Centers for Disease Control and Prevention (the CDC) shaping the beliefs of an easily freaked-out populace, president and legislature, the vaccine industry presents a blueprint for fast-tracking through the regulatory process a new, potentially dangerous, and likely untested vaccine that will be easily marketed to blindly pro-vaccine clinics and blindly pro-vaccine physicians to be given to every scared-out-of-their-wits patient in hearing range whose insurance will cover the unaffordable costs.
This is American capitalism, folks, and what is happening before our eyes is the old, tried and true strategy to siphon off a few billion dollars from us taxpayers and at the same time jack up the stock price of the corporation.
In retrospect, by the way, my father’s pro-vaccine 1970s internist was not unlike the current crop of doctors. He had been indoctrinated in med school with the notion that all vaccines are safe and effective, despite the fact that vaccines have never had to go through the rigorous science that most drugs have to do to get approval. He was totally in the dark about what had caused the Guillain-Barre syndrome (he said it was the virus).
He was also oblivious to the fact that mercury (which is still in flu shots and our dentist’s “silver” dental fillings to this day) was a serious poison to all tissues, particularly nerve and brain tissue. Unaware of his missed diagnosis (of the root cause), his ignorance made him continue to blindly inoculate the other patients in his clinic, many of whom were likely damaged in any number of ways by the unnecessary – and dangerous – toxic vaccine ingredients.
Since then, I have been confronted with uncounted numbers of patients and stories about the seriously adverse effects of mercury-containing vaccines, aluminum-containing vaccines, and fluoride-containing prescription drugs - especially when they are cavalierly injected into the muscles of tiny infants whose blood-brain barriers are at their most immature and who are increasingly likely to suffer permanent brain damage, especially when the shots are given in unproven combinations. (Some tiny infants - at their 2, 4 or 6 month doctor visits receive as many as eight different antigens at a time, each shot containing potentially neurotoxic substances [aluminum, mercury, formaldehyde, antibiotics, viral particles, unfilterable contaminants, etc] that have additive toxic effects and - what is far worse - synergistic effects when given simultaneously.)
Recently cunning lobbyists from multinational corporations, particularly the vaccine industry, the genetically-altered mosquito industry, the insecticide and mosquito repellant industries, etc have been influencing the CDC and many well-meaning folks in the legislative and executive branches of government (including President Obama), creating a Zika virus freak-out no different from the other pseudo-epidemic hoaxes in the past (Swine Flu, Bird Flu, Avian Flu, SARS, etc, etc.)
In my reading and research, I came across a CDC document that claimed to teach physicians about the toxicology of aluminum. The book-length opus (see a few excerpts below) had been approved by the notorious (at least in vaccine skeptic circles) Dr Julie Gerberding, who had gone through the infamous government service-directly-to-industry revolving door in 2009. In Dr Gerberding’s case she went from CDC public service official (where, as head of the CDC, she had shepherded Merck’s untested-for-long-term-safety-OR-efficacy, the first Human Papilloma Virus vaccine Gardisil]) to soon become Director of Merck & Company’s Vaccine Division. See more of the outrageous financial details below (hint: she received a reported $2.5 million salary at Merck, with generous stock options from the company as well).
I am outraged by the poor research that had been done by the various governmental agencies that are supposed to be regulating corporations. Everybody admits it is a fox ruling the henhouse situation. Most of the research quoted in the CDC aluminum toxicology document below was from the 1980s and 1990s, totally ignoring all the new sobering research that reveals how seriously poisonous are aluminum-adjuvanted vaccines. There is no recognition that vaccines are dangerous.
For more details about the new research on the neuro-toxicology of aluminum adjuvants, and the unlikelihood that the Brazilian microcephaly epidemic was caused by a mosquito virus, please google “Zika Virus Freakout – Gary Kohls” and read my series of columns on the subject. Then for much more click on http://duluthreader.com/articles/2015/02/18/4846_vaccine_induced_immune_overload_and_the_epidemic-1 to read a number of columns that I have written over the past 14 months on related topics, including mitochondrial damage from vaccine ingredients, brain damage from prescription drugs and vaccines and many other articles on the vitally important now well-established ASIA syndrome that the CDC, FDA, AAP, AMA, AAFP and the medical establishment are either ignorant about or are otherwise refusing to acknowledge (google the Autoimmune/inflammatory Syndrome Induced by Adjuvants).
In the meantime read the following CDC document that hardly mentions the now well-known fact that aluminum is a neurotoxin that, when it damages the brains of fetuses, is then legitimately called a teratogen. (A teratogen is any substance that can disturb the development of an embryo or fetus and thus cause a birth defect in the child.) The document talks about the toxicity of aluminum being given by mouth or inhalation or trans-dermally (through the skin) and even intravenously, but never mentions that aluminum-adjuvanted vaccines are injected intramuscularly, where they are dramatically more toxic than by any other route. It is a frightening example of bad science, which translates, of course, into bad medicine.
The CDC should be apologizing to every vaccine-injured baby, child, adult and family member and until it does, its veracity in the future needs to be constantly questioned. Here are portions of the 2008 document, which, to my knowledge, has not been updated. The italicized sentences immediately below have been added to the text by myself, and the underlining in the main text was also added by myself, in order to highlight certain important points, omissions or distractions.
TOXICOLOGICAL PROFILE FOR ALUMINUM
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service Agency for Toxic Substances and Disease Registry
Posted at: http://www.atsdr.cdc.gov/toxprofiles/tp22.pdf
A Toxicological Profile for Aluminum, Draft for Public Comment, was released in September 2006. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact:
Agency for Toxic Substances and Disease Registry (ATSDR) Division of Toxicology and Environmental Medicine/Applied Toxicology Branch 1600 Clifton Road NE Mailstop F-32 Atlanta, Georgia 30333
ATSDR Information Center email address: firstname.lastname@example.org
Staff of the Centers for Disease Control and Prevention and other Federal scientists have also reviewed the profile. In addition, this profile has been peer-reviewed by a nongovernmental panel and was made available for public review. Final responsibility for the contents and views expressed in this toxicological profile resides with ATSDR.
Document signed by Howard Frumkin M.D., Dr.P.H., Director, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (ATSDR)
and Julie Louise Gerberding, M.D., M.P.H, Administrator, Agency for Toxic Substances and Disease Registry (ATSDR)
Important note: Dr Gerberding was appointed by George W. Bush to serve as CDC Director starting in 2002. She was highly influential in subverting the massive amount of evidence that proved, in the minds of many scientists, physicians and millions of American parents, that the CDC’s over-vaccination schedule of infants and children was the basis of the huge autism epidemic (partially caused, incidentally, by Dr Gerberding’s future employer Merck & Co, vaccine industry giant and marketer of the dangerous and increasingly discredited HPV vaccine Gardisil ).
Dr Gerberding resigned her post at the CDC on January 21, 2009, when President Obama asked for her resignation.
In late 2009, Dr Gerberding was hired by Merck & Co. Inc, and a year later became President of Merck's Vaccines Division at an estimated salary of $2.5 million per year. She “served” as vaccine director for 5 years and, in January 2015, was promoted to Executive Vice President of Strategic Communications, Global Public Policy and Population Health at Merck & Co. Inc.
In a stock transaction dated May 8th, 2015, Dr Gerberding sold 38,368 shares of Merck stock on the open market. The stock was sold at an average price per share of $60.99, for $2,340,000. Earlier that day, she had exercised 46,208 stock options that had been granted her from Merck in 2011 and 2012.
SEC data posted at: http://www.sec.gov/Archives/edgar/data/310158/000122520815011802/xslF345X01/doc4.xml
Excerpts below are from the following pages of
“TOXICOLOGICAL PROFILE FOR ALUMINUM”:
HOW MIGHT I BE EXPOSED TO ALUMINUM?
People are exposed to aluminum in some cosmetics, antiperspirants, and pharmaceuticals such as antacids and buffered aspirin.
- Antacids have 300–600 mg aluminum hydroxide (approximately 104– 208 mg of aluminum) per tablet, capsule, or 5 milliliter (mL) liquid dose. Little of this form of aluminum is taken up into the bloodstream.
- Buffered aspirin may contain 10–20 mg of aluminum per tablet
- Vaccines may contain small amounts of aluminum compounds, no greater than 0.85 mg/dose.
HOW CAN ALUMINUM ENTER AND LEAVE MY BODY?
Enter your body
A small amount of the aluminum you breathe will enter your body through your lungs.
A very small amount of the aluminum in food or water will enter your body through the digestive tract. An extremely small amount of the aluminum found in antacids will be absorbed.
A very small amount may enter through your skin when you come into contact with aluminum.
Leave your body
Most aluminum in food, water, and medicines leaves your body quickly in the feces. Much of the small amount of aluminum that does enter the bloodstream will quickly leave your body in the urine.
HOW CAN ALUMINUM AFFECT CHILDREN?
This section discusses potential health effects in humans from exposures during the period from conception to maturity at 18 years of age.
Effects in children
Brain and bone disease caused by high levels of aluminum in the body have been seen in children with kidney disease. Bone disease has also been seen in children taking some medicines containing aluminum. In these children, the bone damage is caused by aluminum in the stomach preventing the absorption of phosphate, a chemical compound required for healthy bones. Aluminum is found in breast milk, but only a small amount of this aluminum will enter the infant’s body through breastfeeding. Typical aluminum concentrations in human breast milk range from 0.0092 to 0.049 mg/L. Aluminum is also found in soy-based infant formula (0.46–0.93 mg/L) and milk-based infant formula (0.058–0.15 mg/L).
We do not know if aluminum will cause birth defects in people. Birth defects have not been seen in animals. Very young animals appeared weaker and less active in their cages and some movements appeared less coordinated when their mothers were exposed to large amounts of aluminum during pregnancy and while nursing. In addition, aluminum also affected the animal’s memory. These effects are similar to those that have been seen in adults. It does not appear that children are more sensitive than adult animals.
HEALTH EFFECTS of Aluminum Exposure
Distribution .................................................................................................................Page 103 Inhalation Exposure ....................................................................................................Page 104 Oral Exposure .............................................................................................................Page 105
Dermal Exposure ........................................................................................................Page 107 Other Routes of Exposure............................................................................................Page 107
The normal level of aluminum in the human brain ranges from 0.25 to 0.75 mg/kg w/w, with gray matter containing about twice the concentration found in the white matter (Alfrey et al. 1976; Arieff et al. 1979; McDermott et al. 1978; Roider and Drasch 1999). There is evidence that with increasing age of humans, aluminum concentrations may increase in the brain tissue (Alfrey 1980; Crapper and DeBoni 1978; Markesbery et al. 1981; McDermott et al. 1979; Stitch 1957; Tipton and Shafer 1964); aluminum levels in serum may also increase with aging (Zapatero et al. 1995).
A portion of the small particles reach the alveoli where they can be transferred to blood (especially for soluble compounds), or taken up by alveolar macrophages through phagocytosis and transported to pulmonary lymph nodes for insoluble compounds.
In addition to distribution of aluminum to the brain (hippocampus), bone, muscle, and kidneys of orally exposed animals, there is evidence in animals that aluminum crosses the placenta and accumulates in the fetus and distributes to some extent to the milk of lactating mothers (Cranmer et al. 1986; Golub et al. 1996; Yokel 1985; Yokel and McNamara 1985).
Elevated levels of aluminum were also observed in the fetus, providing evidence of transplacental transfer of aluminum.
Other Routes of Exposure
When there is inadequate elimination of aluminum from the body, as in nondialyzed uremic patients, increased aluminum concentrations are detected in serum, bone tissue, liver, spleen, brain, and skeletal muscle (Alfrey et al. 1980; Arieff et al. 1979). In hemodialysis patients exposed by infusion to large amounts of aluminum over long periods of time (with inadequate removal of aluminum by the kidneys and dialysis machines), increased aluminum concentrations are observed mostly in the spleen, followed by the liver and skeletal system (Alfrey 1980; Alfrey et al. 1980). A study in rabbits found a significantly lower serum half-life in renally-impaired animals, as compared to renally-intact animals (27 hours versus 14 hours); this is likely due to the diminished volume of distribution in the renally-impaired rabbits (Yokel and McNamara 1988).
The distribution of aluminum following intravenous, subcutaneous, intraperitoneal, and intramuscular exposure has been evaluated in studies with experimental animals (Cranmer et al. 1986; Du Val et al. 1986; Flarend et al. 1997; Leblondel and Allain 1980; Yokel and McNamara 1985, 1989; Yokel et al. 2001b). Results of these animal studies indicate that aluminum distributes to a number of tissues, organs, and biological fluids (Du Val et al. 1986; Leblondel and Allain 1980; Yokel and McNamara 1989).
In rabbits given a single intravenous dose of aluminum lactate, aluminum concentrations did not increase above controls in the cerebellum, white brain tissue, hippocampus, spinal cord, adrenal glands, bone, heart, testes, or thyroid (Yokel and McNamara 1989). Treated animals did have significant increases of aluminum in the liver, serum, bile, kidneys, lungs, and spleen. Throughout the 128 day study, the liver of exposed rabbits had over 80% of the total body burden of aluminum. Persistence of aluminum in the various tissues, organs, and fluids varied. Estimated half-times of aluminum were 113, 74, 44, and 42 days in the spleen, liver, lungs, and serum, respectively. The kidneys of treated rabbits demonstrated
two half-times with an initial time of 4.2 and 2.3 days for the renal cortex and renal medulla, respectively, and a second half-time of >100 days for kidney in general; the relative amounts subject to each half-time were not addressed. The half-life of aluminum in the brain of rats receiving an intravenous dose of aluminum citrate was approximately 150 days (Yokel et al. 2001b).
Subcutaneous injection of rabbits with aluminum chloride daily for 28 days was associated with significant accumulation of aluminum (measured at the end of the exposure period) in bone, followed in order by significantly increased aluminum concentrations in renal cortex, renal medulla, liver, testes, skeletal muscle, heart, brain white matter, hippocampus, and plasma (Du Val et al. 1986). Because the brain tissue of treated rabbits had the lowest aluminum concentrations of the tissues evaluated, the authors suggested that there was a partial blood-brain barrier to entry of aluminum.
Distribution of aluminum to tissues following intraperitoneal exposure depends in part on the type of aluminum compound administered and on the aluminum concentration in blood (Leblondel and Allain 1980). Mice were administered 54 mg Al/kg as aluminum chloride, nitrate, lactate, or gluconate by a single intraperitoneal injection. The blood concentrations of aluminum, which reached a peak within 20 minutes, increased significantly with gluconate (99.5 mg/L), increased to high levels with lactate (4.5 mg/L), and increased marginally with nitrate and chloride (0.3 mg/L). Aluminum concentrations in the brain tissue of treated mice significantly increased only with aluminum gluconate and only at extremely high blood aluminum concentrations of 20–100 mg/L; the half-life of aluminum in the brain was approximately 90 minutes. At blood aluminum concentrations of 2–4 mg/L, there was no increase in brain aluminum with any of the compounds evaluated. Interpretation of this study is limited by the short monitoring period (apparently 80 minutes); thus, the study does not take into consideration possible differences in absorption rate between aluminum compounds. Differences in brain aluminum levels following administration of different aluminum compounds may also be due to the presence of carrier systems that can transport aluminum into or out of the brain; this has been demonstrated for aluminum citrate (Allen et al. 1995).
Following intramuscular administration of aluminum hydroxide or aluminum phosphate vaccine adjuvants in rabbits, increased levels of (radio-labeled) 26Al were found in the kidney, spleen, liver, heart, lymph nodes, and brain (in decreasing order of aluminum concentration) (Flarend et al. 1997).
There is also evidence from animal studies indicating that aluminum administered parenterally accumulates to a small extent in the milk of lactating mothers, and that aluminum crosses the placenta and
accumulates in fetal tissue (Cranmer et al. 1986; Yokel and McNamara 1985; Yumoto et al. 2000). Intraperitoneal exposure of pregnant mice to aluminum chloride on gestation days 7–16 has been associated with significantly increased concentrations of aluminum in both placental and fetal tissues (Cranmer et al. 1986). Following a single subcutaneous injection of 26Al on gestation day 15, 0.2 and 0.21% of the dose was detected in the placenta and fetus, respectively, 5 days after the injection (Yumoto et al. 2000). Within the fetus, the level of 26Al in the brain was as high as 30% of that in the fetal liver; in contrast, the level of 26Al in the brain of the dam was only 1% of the level in the liver. Intravenous, intraperitoneal, or subcutaneous exposure of lactating rats, rabbits, or mice to aluminum lactate or aluminum chloride has been associated with increased concentrations of aluminum in milk (Muller et al. 1992; Yokel and McNamara 1985). The amount of aluminum detected in milk 24 hours after exposure was estimated to be 2.4% of the intravenous dose and 3.3% of the subcutaneous dose (Yokel and McNamara 1985). Subcutaneous injection of 26Al in rats on lactation day 1 through 20, resulted in significant elevation in aluminum levels in the suckling rats (Yumoto et al. 2000, 2003). On lactation day 2, elevated levels of 26Al were detected in the liver, but not in the kidney, brain, or blood; 26Al was detected in these tissues on lactation day 9 (Yumoto et al. 2000).
Dr Kohls is a retired physician who practiced holistic, non-drug, mental health care for the last decade of his family practice career. He now writes a weekly column for the Reader Weekly, an alternative newsweekly published in Duluth, Minnesota, USA. Many of Dr Kohls’ columns are archived at http://duluthreader.com/articles/categories/200_Duty_to_Warn and at http://www.globalresearch.ca/author/gary-g-kohls.